Do you have questions about clinical trials? Have you considered looking into trials, but did not know where to start? Attend “Unlocking Secrets of Clinical Trials: What You Need to Know about Phases” to learn more about clinical trials from Dr. Federico Rodriguez-Porcel, principal investigator of LBDA’s Research Center of Excellence at the Medical University of South Carolina. Dr. Rodriguez-Porcel will provide a high-level overview of the drug development process, taking a deeper look at the three main “phases” of clinical trials, and the role and rights of research volunteers. Attendees will also have an opportunity to have their questions addressed.
Key Takeaways:
- Drug development is a long, complex process: From concept to drug approval, there are numerous steps and the process takes years; most drug candidates are not successful; once clinical trials begin, hundreds to thousands of volunteers are needed.
- There are three main phases of trials: Each of the three phases from 1-3 will be described, including their focus on safety, efficacy, or both; approximate number and characteristics of volunteers; what a volunteer should expect at study visits; kinds of data that result; FDA’s role and expectations.
- While all clinical trials involve risk, volunteers have protections and control: Topics covered in this section include role of the IRB, informed consent, right of withdrawal, and who to contact with concerns.
Federico Rodriguez-Porcel, M.D. is an assistant professor of neurology in the Movement Disorders and Behavioral Neurology Divisions at the Medical University of South Carolina. He obtained his medical degree from Universidad del Salvador in Buenos Aires, Argentina. He completed his internship, and neurology residency at Loyola University Medical Center, in Maywood, Illinois, where he served as chief resident in his last year. Subsequently, Dr. Rodriguez-Porcel completed separate fellowships in movement disorders and behavioral neurology and neuropsychiatry at the University of Cincinnati. He is board certified by the American Board of Psychiatry and Neurology and board-certified for Behavioral Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties, His areas of interest include cognitive aspects of movement disorders, particularly those related to communication. He is funded by the NIH.
Register Today: https://events.zoom.us/ev/AvF10J-3VnukwRD9tYGHWW0ROKGs9Icv8sS6sBvudf4AVAarKGLe~AipgdVpYmaroMpLUgGuOhzcPyX6i0fgRMlm1VX847Iakd2V4uLgeYW222A
For questions or more information, please contact Rose Heithoff, Education Coordinator, at [email protected].
